Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology
Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology
复制标题
DOI:
10.1038/mp.2011.128
复制
发表时间:
2012-07-01
影响因子:
11
通讯作者:
Torres-Aleman, I.
中科院分区:
文献类型:
--
作者:
Fernandez, A. M.;Jimenez, S.;Torres-Aleman, I.
Whether insulin-like growth factor I (IGF-I) signaling in Alzheimer's disease (AD) is beneficial or detrimental remains controversial. We now show that a competitive regulation by IGF-I of the phosphatase calcineurin in reactive, but not in quiescent astrocytes drives Alzheimer's pathology. Calcineurin de-phosphorylates the transcription factor Foxo3 in response to tumor necrosis factor-alpha (TNF alpha), an inflammatory cytokine increased in AD, activating nuclear factor-kappa B (NF kappa B) inflammatory signaling in astrocytes. In turn, IGF-I inactivates and displaces Foxo3 from calcineurin in TNF alpha-stimulated astrocytes by recruiting the transcription factor peroxisome proliferator-activated receptor-gamma, and NF kappa B signaling is inhibited. This antagonistic mechanism reversibly drives the course of the disease in AD mice, even at advanced stages. As hallmarks of this calcineurin/Foxo3/NF kappa B pathway are present in human AD brains, treatment with IGF-I may be beneficial by antagonizing it. Molecular Psychiatry (2012) 17, 705-718; doi:10.1038/mp.2011.128; published online 18 October 2011